Wall Street lifted target prices across several names on September 4, with life sciences and semiconductors leading the action.
RVTY saw the sharpest consensus move. Revvity's average analyst target rose to $125.25 from $122.75. The $14.6 billion diagnostics and life-sciences tools company carries short interest of 6.7% of free float. That is modest, suggesting limited bearish conviction from institutional traders.
INTC attracted a target price lift to $115.78. Intel's consensus now sits at 31 Hold and 14 Buy recommendations. The upgrade cycle reflects growing optimism around the chip giant's foundry restructuring. Short interest stands at just 2.9% of free float.
CRWD received a target increase to $231.24 from $226.57. CrowdStrike holds 37 Buy ratings. Cybersecurity demand remains strong heading into year-end budget cycles.
FLEX was the lone bearish call. Analysts cut the electronics manufacturing giant's consensus target to $158.33 from $160.50. Flex carries a $39 billion market cap.
Homebuilders also drew fresh coverage. New recommendations landed on and . Both stocks leaned toward Buy-to-Hold splits, reflecting a cautious stance on housing demand.
NVDA and AVGO attracted further target increases, reinforcing the AI-driven chip sector's dominant position among analyst buy lists.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
